CompletedNot applicableNCT00957424

Acceptability of Less Harmful Alternatives to Cigarettes

RATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking. PURPOSE: This clinical trial is studying the acceptability of less harmful alternatives to cigarettes.

Checked against the public recordLast updated Feb 7, 2017 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorRoswell Park Cancer Institute
01
Study overview

What this study is about

Purpose
Not specified
Study type
Interventional
Phase
Not applicable
Sponsor
Roswell Park Cancer Institute
Interventions being studied
Behavioral: telephone-based intervention; Drug: nicotine replacement therapy; Other: informational intervention; Other: internet-based intervention; Other: questionnaire administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

DISEASE CHARACTERISTICS: * Currently smokes ≥ 10 cigarettes per day * Not planning to quit smoking in the next 30 days and has not tried to quit in the past 30 days * Medically eligible to receive nicotine-replacement products, based on the NYS Smokers Quitline eligibility criteria PATIENT CHARACTERISTICS: * Not pregnant or nursing * Able to read and speak English * In good general health * No history of heart attack or stroke in the past 2 weeks * No history of chest pains in the past month * No report of physician-diagnosed arrhythmia/irregular heartbeat or use of pacemaker * No report of physician-diagnosed heart disease/coronary artery disease, uncontrolled hypertension, stomach ulcer, diabetes, depression, or asthma PRIOR CONCURRENT THERAPY: * No other concurrent tobacco products or nicotine medications * No concurrent Zyban, Bupropion, Wellbutrin, Chantix, or other smoking cessation medication

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Roswell Park Cancer InstituteBuffalo, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 7, 2017. Always confirm current availability with the study team.

View original record ↗